Grifols | GRFS - EPS Earnings Per Share


Grifols reported EUR0.16 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2025 0.31 0.21 Nov/10
FY2025Q1 Mar/2026 0.17 0.17 0.24 May/07




Eps Change Date
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Arca Biopharma USD -0.54 0.14 Dec/2025
aTyr Pharma USD -0.06 0.59 Mar/2026
Bio Path USD -0.07 0.48 Sep/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Grifols EUR 0.16 0.02 Mar/2026
Immunic USD -0.1 0.03 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024